학술논문
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study
Document Type
Article
Author
Brooks, Kristina M ; Kiser, Jennifer J; Ziemba, Lauren; Ward, Shawn; Rani, Yasha; Cressey, Tim R; Masheto, Gaerolwe R; Cassim, Haseena; Deville, Jaime G; Ponatshego, Ponego L; Patel, Faeezah; Aurpibul, Linda; Barnabas, Shaun L; Mustich, Iris; Coletti, Anne; Heckman, Barbara; Krotje, Chelsea; Lojacono, Mark; Yin, Dwight E; Townley, Ellen; Moye, Jack; Majji, Sai; Acosta, Edward P; Ryan, Kevin; Chandasana, Hardik; Brothers, Cynthia H; Buchanan, Ann M; Rabie, Helena; Flynn, Patricia M
Source
In The Lancet HIV August 2023 10(8):e506-e517
Subject
Language
ISSN
2352-3018